Ureteroscopy-assisted retrograde nephrostomy (UARN) for the patients with cerebrotendinous xanthomatosis

Introduction: Ureteroscopy-assisted retrograde nephrostomy (UARN) makes it is possible to continuously visualize dilation of the ureter from the site of puncture to insertion of the nephroaccess sheath, with minimal complications and effective for percutaneous nephrolithotripsy (PCNL). Case Report: A 43-year-old male with cerebrotendinous xanthomatosis (CTX) was referred to our department to undergo PCNL for a diagnosis of a right kidney stone. In July 2012, the patient was admitted to our department for PCNL to treat a right renal staghorn calculus. We performed PCNL using the technique of UARN. The operative time was 195 minutes, and the chemical composition of the stone was calcium oxalate. Conclusion: UARN is effective for the case who have large renal stone with complications of CTX. (This page in not part of the published article.) International Journal of Case Reports and Images, Vol. 6 No. 12, December 2015. ISSN – [0976-3198] Int J Case Rep Images 2015;6(12):777–779. www.ijcasereportsandimages.com Kawahara et al. 777 CASE REPORT OPEN ACCESS Ureteroscopy-assisted retrograde nephrostomy (UARN) for the patients with cerebrotendinous xanthomatosis Takashi Kawahara, Hiroki Ito, Hideyuki Terao, Hiroji Uemura, Masahiro Yao, Junichi Matsuzaki


INtrODUctION
We previously described the use of ureteroscopyassisted retrograde nephrostomy (UARN), which makes it is possible to continuously visualize dilation of the ureter from the site of puncture to insertion of the nephro access sheath, with minimal complications [1,2]. We herein report the first case in which UARN was applied for percutaneous nephrolithotripsy (PCNL) in a patient with cerebrotendinous xanthomatosis (CTX).

cAsE rEPOrt
A 43-year-old male with CTX was referred to our department to undergo nephrolithotripsy for a diagnosis of a right kidney stone. In July 2012, the patient was admitted to our department for PCNL to treat a right renal staghorn calculus. We have previously reported the technique of UARN and performed this procedure in the present case, as described below [1].
Briefly, under general and epidural anesthesia, the patient is placed in a modified Valdivia position (Galdakao modified Valdivia position). Flexible URS (Flex-X2, Tuttlingen, Karl Storz, Germany) insertion is carried out under an inserted ureteral access sheath in the ureter after ensuring that the rigid URS (Uretero-renoscope, Karl Storz, Tuttlingen, Germany) does not encounter either ureteral stenosis or stones. The UAS device includes a In order to avoid injury to the spleen, liver, intestines or pleural cavity, a puncture is then performed under ultrasonography after rechecking the preoperative computed tomography (CT) scan. The puncture wire is easily passed through the muscle and "tents" the skin at the posterior axial line. The skin is then incised, and the needle is delivered. Next, the dilator is placed using the puncture wire. A 24-Fr percutaneous nephro-access sheath (X-Force®N30 Nephrostomy Balloon Dilation Catheter, BARD, USA) is passed over the balloon into the calyx under ureteroscopic and fluoroscopic guidance, after which the balloon is removed. Calculus fragmentation is performed using the Swiss LithoClast® pneumatic lithotripter (EMS, Nyon, Switzerland) through a rigid nephroscope (percutaneous nephroscope, Karl Storz, Tuttlingen, Germany).

CASE REPORT PEER REviEwEd | OPEN ACCESS
The operative time was 195 minutes, and the chemical composition of the stone was calcium oxalate.

DIscUssION
Cerebrotendinous xanthomatosis (CTX) is a rare neurological disease characterized by the accumulation of cholesterol and cholestanol in the brain and tendons due to a mutation in the sterol 27-hydroxylase gene (CYP27A1). More than 400 cases have been previously described worldwide in medical literature [3]. The clinical signs of CTX develop gradually during the patient's lifetime. Some patients exhibit mental impairment in childhood, whereas others do not display any neurological symptoms, even at an older age, with the only sign of the disease being Achilles tendon xanthoma formation [4]. Premature atherosclerosis and cardiac complications have been reported to be systemic manifestations of CTX [5]. In some cases, myocardial infarction is the cause of sudden death.
The mean age of symptom onset is estimated to be between 14 and 19 years of age, with a mean delay in diagnosis of 17-19 years. Early typical signs include chronic diarrhea, juvenile bilateral cataracts, Achilles (or other) tendon xanthomas, psychomotor retardation, cognitive impairment with learning difficulties or mental retardation, cerebellar ataxia and epilepsy, which can affect up to 50% of patients [3]. Other late-stage neurological features comprise pyramidal tract signs with extensor plantar responses, progressive spastic paraplegia, progressive cerebellar ataxia and dysarthria, nystagmus, peripheral polyneuropathy with distal muscle wasting and, more rarely, movement disorders, such as parkinsonism and palatal myoclonus, and, in patients with advanced disease, pseudobulbar and bulbar syndromes [3]. As the disorder progresses, the patient can become incapacitated due to motor dysfunction, with premature death often occurring as a result of advancing neurological deterioration. Treatment is based on the administration of chenodeoxycholic acid. The early detection of CTX is essential, as drug therapy can limit further damage to the CNS and prevent progression of tendon xanthomas, as well as lead to regression in early cases.
Although the effectiveness of shock wave lithotripsy (SWL) and flexible ureteroscopic lithotripsy has been reported, patients with a greater stone burden are thought to be better candidates for PCNL. Previously, nephrostomy was usually transcutaneously performed under ultrasonographic and/or fluoroscopic guidance. With the arrival and development of flexible ureteroscopy (URS), both observation and manipulation in the renal pelvis can be easily achieved. We previously described a new technique for performing UARN. This procedure involves less radiation exposure and a shorter operative time than the previous percutaneous nephrostomy method. Our technique represents an additional new option for performing PCNL in patients with a nondilated intrarenal collecting system.
Due to the continuous visualization offered by URS, the use of UARN facilitates PCNL to be performed more safely and easily [2]. This report describes the first case of nephrolithiasis treated with UARN in a patient with CTX.

Edorium Journals: An introduction
Edorium Journals Team

But why should you publish with Edorium Journals?
In less than 10 words -we give you what no one does.

Vision of being the best
We have the vision of making our journals the best and the most authoritative journals in their respective specialties. We are working towards this goal every day of every week of every month of every year.

Exceptional services
We care for you, your work and your time. Our efficient, personalized and courteous services are a testimony to this.

Editorial Review
All manuscripts submitted to Edorium Journals undergo pre-processing review, first editorial review, peer review, second editorial review and finally third editorial review.

Peer Review
All manuscripts submitted to Edorium Journals undergo anonymous, double-blind, external peer review.

Early View version
Early View version of your manuscript will be published in the journal within 72 hours of final acceptance.

Manuscript status
From submission to publication of your article you will get regular updates (minimum six times) about status of your manuscripts directly in your email.

Most Favored Author program
Join this program and publish any number of articles free of charge for one to five years.

Favored Author program
One email is all it takes to become our favored author. You will not only get fee waivers but also get information and insights about scholarly publishing.

Institutional Membership program
Join our Institutional Memberships program and help scholars from your institute make their research accessible to all and save thousands of dollars in fees make their research accessible to all.

Our presence
We have some of the best designed publication formats. Our websites are very user friendly and enable you to do your work very easily with no hassle.

Something more...
We request you to have a look at our website to know more about us and our services.
We welcome you to interact with us, share with us, join us and of course publish with us.

Invitation for article submission
We sincerely invite you to submit your valuable research for publication to Edorium Journals.

Six weeks
You will get first decision on your manuscript within six weeks (42 days) of submission. If we fail to honor this by even one day, we will publish your manuscript free of charge.

Four weeks
After we receive page proofs, your manuscript will be published in the journal within four weeks (31 days). If we fail to honor this by even one day, we will publish your manuscript free of charge and refund you the full article publication charges you paid for your manuscript.